{"id":481610,"title":"Notice of Intent to Amend the Prescription Drug List: Metamizole (dipyrone) - Canada.ca - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:05:51.448000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-metamizole.html?wbdisable=true","snippet":"Notice of Intent to Amend the Prescription Drug List: Metamizole (dipyrone) January 18, 2022 Our file number: 22-100544-803 The purpose of this Notice of Intent to Amend is to announce that metamizole (also known as ‘dipyrone’) will be added to the Prescription Drug List (PDL).…","rawSnapshotUrl":"/api/snapshots/raw/481610","browseUrl":"https://replay.healtharchive.ca/job-6/20260106170551/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-metamizole.html?wbdisable=true#ha_snapshot=481610","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}